Ambulatory Surgery Center EBITDA Multiples: 5x–9x — What Buyers Pay (2026)
Physician-owned ASCs with diversified payer mix, Medicare certification, and strong case volume command premium multiples from PE platforms and health systems.
Ambulatory Surgery Centers in the lower middle market ($1M–$5M revenue) typically trade at 5x to 9x EBITDA. Valuation is driven by payer mix quality, EBITDA margin, specialty diversification, accreditation status, and physician retention risk. PE roll-up buyers and regional health systems compete aggressively for certified, high-margin ASCs with clean compliance histories.
Ambulatory Surgery Center EBITDA Multiples (2026)
| Practice Size | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed or Single-Specialty | $200K–$500K | 5x–6x | High physician concentration risk, aging equipment, weak payer mix, or unresolved CMS compliance issues suppress buyer interest and pricing. |
| Stable Independent ASC | $500K–$1M | 6x–7x | Medicare-certified, single-location ASC with solid margins but limited specialty mix or payer contract depth. Solid but not premium positioning. |
| Multi-Specialty Growth ASC | $1M–$2M | 7x–8x | Diversified specialty mix, strong payer contracts, AAAHC or Joint Commission accreditation, and documented case volume growth attract competitive bidding. |
| Premium Platform-Ready ASC | $2M+ | 8x–9x | PE roll-up ready with multiple OR suites, deep physician network, above-market reimbursement rates, and clean regulatory history command top-of-range multiples. |
Valuation Drivers — What Makes Your Multiple Higher or Lower
The spread between 3.5x and 6.5x is not random. These seven factors determine where your firm lands.
Payer Mix and Reimbursement Quality
HighASCs with Medicare, commercial-dominant payer mix and locked-in above-average reimbursement rates for 2+ years achieve meaningfully higher multiples than Medicaid-heavy or uninsured-dependent centers.
Physician Ownership and Retention Risk
HighRevenue concentrated among one or two surgeons creates key-man risk that compresses multiples. Buyers reward diversified physician partnerships with documented retention plans and rollover equity.
Accreditation and Regulatory Compliance
HighAAAHC or Joint Commission accreditation and clean Medicare certification signal operational credibility. Unresolved CMS audits, overpayment demands, or CON violations are significant valuation discounts.
Specialty and Case Volume Mix
MediumOrthopedic, ophthalmology, and GI-heavy case mixes command buyer preference. Declining case volumes or heavy reliance on retiring physicians without succession plans reduce enterprise value materially.
EBITDA Margin and Operational Efficiency
MediumCenters sustaining 25%+ EBITDA margins through disciplined scheduling, supply chain management, and low overhead demonstrate scalability that PE buyers underwrite at premium acquisition multiples.
Recent Market Trends
PE-backed ASC roll-up activity intensified through 2023–2024 as CMS continued shifting high-acuity procedures to outpatient settings, expanding the addressable case mix. Competitive bidding from regional health systems has compressed cap rates on premium ASCs. Reimbursement rate uncertainty from CMS 2025 proposed rules is introducing modest valuation caution at the lower tier.
Who Buys Ambulatory Surgery Centers in 2026
Individual Operator / Search Fund
Entrepreneurship through acquisition (ETA), first-time buyers, industry-adjacent operators
What they want: Stable, transferable cash flow in a Ambulatory Surgery Center. SBA-eligible business, strong revenue quality, and a seller available for a 12–18 month transition.
Pros for seller
- +SBA 7(a) financing means 10% buyer equity — faster than waiting for institutional capital
- +Buyer works inside the business, maintaining client and staff relationships
- +Deal structure is typically straightforward: cash at close plus seller note
Cons for seller
- −Lower multiples than PE buyers — typically at the low-to-mid end of the range
- −Requires meaningful seller involvement post-close for transition
- −SBA approval timeline adds 60–90 days to closing
PE-Backed Roll-Up Platform
Private equity consolidators building a Ambulatory Surgery Center portfolio, regional or national platforms
What they want: Scale, operational quality, and geographic coverage. Strong revenue quality with minimal owner dependency. Clean financials, documented systems, and staff who can operate without the selling owner.
Pros for seller
- +All-cash close with no SBA financing contingency or approval delay
- +Highest multiples available for premium businesses
- +Equity rollover option — seller keeps 10–30% stake and participates in platform exit
Cons for seller
- −Extensive 90–150 day due diligence process
- −Post-close integration into a larger platform changes operating culture
- −Usually requires seller to remain in a leadership role for 12–24 months
Strategic Acquirer
Larger Ambulatory Surgery Center operators, adjacent-industry buyers adding capacity or geography
What they want: Client relationships, staff, and market position that complement their existing operations. revenue quality is especially valuable when it fills a gap the buyer can't easily build organically.
Pros for seller
- +Can pay above-model multiples for strong strategic fit
- +Buyer already understands the business — diligence is faster
- +Shorter transition requirement when operational overlap exists
Cons for seller
- −Fewer competing buyers — less leverage in negotiation
- −Non-compete scope typically broader than PE or individual deals
- −Operations and brand may change significantly post-close
Sample Ambulatory Surgery Center Transactions
Two-OR orthopedic and pain management ASC in the Southeast, Medicare-certified, AAAHC accredited, diversified physician partnership with 6 active surgeons.
$1.4M
EBITDA
7.8x
Multiple
$10.9M
Price
Single-specialty GI-focused ASC in a Midwest suburban market, strong commercial payer contracts, stable case volume, sole physician-owner with partial rollover equity.
$650K
EBITDA
6.2x
Multiple
$4.0M
Price
Multi-specialty ASC with orthopedic, ophthalmology, and ENT service lines, three OR suites, Joint Commission accredited, acquired by PE-backed healthcare platform as add-on.
$2.1M
EBITDA
8.5x
Multiple
$17.9M
Price
EBITDA Valuation Estimator
Get your Ambulatory Surgery Center business value range instantly
Industry: Ambulatory Surgery Center · Multiples based on 6x–7x (Stable Independent ASC)
Powered by DealFlow OS
dealflow-os.com · Free M&A tools for every stage of the deal
How to Use These Multiples
For Sellers: 4-Step Valuation Walkthrough
- 1
Compile three years of P&L statements and tax returns that reconcile line by line — SBA lenders and institutional buyers both require this, and any unexplained gap triggers diligence delays or price renegotiation.
- 2
Build a normalized EBITDA schedule with every add-back documented: owner W-2 above a market-rate manager salary, personal expenses, one-time items, and non-recurring costs. Undocumented add-backs get cut.
- 3
Address your owner dependency before going to market — this is the most common reason Ambulatory Surgery Center businesses receive offers at the low end of the 5x–9x range. Buyers identify it in diligence and reprice accordingly.
- 4
Quantify and document your revenue quality with supporting records: contracts, renewal histories, client revenue breakdowns. This is the primary evidence for commanding a premium multiple, and you need it before the first buyer call.
For Buyers: Validate the Asking Multiple
- 1
Request trailing 12-month and 3-year P&L with bank statement backup before making an offer. If a Ambulatory Surgery Center seller can't produce reconciled financials, that's a signal about what the full diligence process will look like.
- 2
Verify the revenue quality claims independently — pull contract copies, renewal documentation, and client-level revenue data. This is the primary driver of whether this Ambulatory Surgery Center is worth 9x or 5x.
- 3
Assess owner dependency directly: ask which revenue or client relationships are personal to the current owner, and what the transition plan is. An exit-ready seller has already thought through this.
- 4
Model your SBA debt service against verified EBITDA before signing the LOI. At current rates, a $1M SBA 7(a) loan runs approximately $13,000/month over 10 years — the business needs at least 1.25x debt service coverage after a market-rate manager salary.
Frequently Asked Questions
What EBITDA multiple should I expect when selling my ambulatory surgery center?
Most ASCs sell at 5x to 9x EBITDA. Premium multiples require Medicare certification, diversified payer mix, multi-specialty case volume, strong margins, and clean compliance history.
Are ambulatory surgery centers eligible for SBA financing?
No. ASC acquisitions are not SBA-eligible due to healthcare regulatory complexity and physician ownership structures. Deals are typically structured through PE capital, health system balance sheets, or MSO frameworks.
How does physician concentration risk affect ASC valuation?
Heavy reliance on one or two surgeons for case volume creates key-man risk that buyers discount heavily. Diversified physician partnerships with retention agreements and rollover equity protect and enhance multiples.
How long does it take to sell a physician-owned ASC?
ASC transactions typically require 18 to 36 months from exit preparation to close due to licensing, accreditation transfer, payer contract assignment, and physician equity consensus requirements.
More Ambulatory Surgery Center Guides
Related Reading
Find Ambulatory Surgery Center businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
No credit card required